Effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats
- PMID: 2394549
Effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats
Abstract
Anisodamine, an atropine analog, is widely used in China for treatment of acute circulatory shock but mechanisms of its action are not fully known. We investigated the effect of anisodamine on different renal vessels in the hydronephrotic kidney. Anisodamine was added to the tissue bath containing the kidney to produce increasing concentrations from 10(-8) to 10(-3) M. Anisodamine dilated the arcuate artery, interlobular artery and afferent arteriole in a dose dependent manner. The maximal dilation of 15 to 25% in these preglomerular vessels was attained at a concentration of about 10(-5) M. In contrast, the efferent arteriole constricted by about 55% in response to anisodamine. The glomerular blood flow increased by 15 and 40% at anisodamine concentrations of 10(-8) and 10(-5) M respectively. The renal vascular effect of anisodamine could be abolished by the dopamine receptor antagonist haloperidol. Our data indicate that anisodamine is a potent vasodilator of preglomerular renal vessels and that its effect is mediated by activation of the dopaminergic system. The action of anisodamine through a dopaminergic mechanism, as found in the hydronephrotic kidney, may also be involved in its antishock properties.
Similar articles
-
[Dopaminergic effect of anisodamine on the microcirculation of the hydronephrotic kidney of rats].J Tongji Med Univ. 1991;11(2):65-72. doi: 10.1007/BF02888091. J Tongji Med Univ. 1991. PMID: 1687750 German.
-
Visualization of renal autoregulation in the split hydronephrotic kidney of rats.Kidney Int. 1989 May;35(5):1151-60. doi: 10.1038/ki.1989.104. Kidney Int. 1989. PMID: 2770100
-
Cysteinyl leukotriene actions on the microcirculation of the normal and split hydronephrotic rat kidney.Eur J Clin Invest. 1991 Apr;21(2):184-96. doi: 10.1111/j.1365-2362.1991.tb01808.x. Eur J Clin Invest. 1991. PMID: 1647953
-
Cell protection mechanism of antishock action of anisodamine.Chin Med J (Engl). 1992 Dec;105(12):976-9. Chin Med J (Engl). 1992. PMID: 1299554 Review.
-
The pharmacological properties of anisodamine.J Appl Toxicol. 2007 Mar-Apr;27(2):116-21. doi: 10.1002/jat.1154. J Appl Toxicol. 2007. PMID: 17186568 Review.
Cited by
-
Protective effect of anisodamine in rats with glycerol-induced acute kidney injury.BMC Nephrol. 2019 Jun 17;20(1):223. doi: 10.1186/s12882-019-1394-y. BMC Nephrol. 2019. PMID: 31208365 Free PMC article.
-
Anisodamine for the prevention of contrast-induced nephropathy in patients with acute coronary syndrome: a pilot systematic review and meta-analysis of randomized controlled trials.Ann Med Surg (Lond). 2024 May 21;86(7):4123-4129. doi: 10.1097/MS9.0000000000002181. eCollection 2024 Jul. Ann Med Surg (Lond). 2024. PMID: 38989215 Free PMC article. Review.
-
Effectiveness of anisodamine for the treatment of critically ill patients with septic shock (ACIdoSIS study): study protocol for randomized controlled trial.Ann Transl Med. 2015 Oct;3(17):246. doi: 10.3978/j.issn.2305-5839.2015.10.03. Ann Transl Med. 2015. PMID: 26605292 Free PMC article.